<産業資料/調査レポートの題名> 2022年6月19日

羊膜の世界市場:種類別、地域別


◆英文タイトル:Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Cryopreserved amniotic membrane – Market size and forecast 2019-2024
• Dehydrated amniotic membrane – Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Growing reimbursement coverage for new products
• Rise in development of new applications through research
• Industry consolidation through mergers and acquisitions
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Celularity Inc.
• Human Regenerative Technologies LLC
• Integra LifeSciences Holdings Corp.
• Katena Products Inc.
• MiMedx Group Inc.
• NuVision Biotherapies Ltd.
• Orthofix Medical Inc.
• Stryker Corp.
• Surgenex LLC
• TissueTech Inc.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Type – Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Cryopreserved amniotic membrane – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Cryopreserved amniotic membrane – Year-over-year growth 2020-2024 (%)
Exhibit 22: Dehydrated amniotic membrane – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Dehydrated amniotic membrane – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Celularity Inc. – Vendor overview
Exhibit 45: Celularity Inc. – Business segments
Exhibit 46: Celularity Inc. – Organizational developments
Exhibit 47: Celularity Inc. – Key customers
Exhibit 48: Human Regenerative Technologies LLC – Vendor overview
Exhibit 49: Human Regenerative Technologies LLC – Product segments
Exhibit 50: Human Regenerative Technologies LLC – Key offerings
Exhibit 51: Integra LifeSciences Holdings Corp. – Vendor overview
Exhibit 52: Integra LifeSciences Holdings Corp. – Business segments
Exhibit 53: Integra LifeSciences Holdings Corp. – Organizational developments
Exhibit 54: Integra LifeSciences Holdings Corp. – Geographic focus
Exhibit 55: Integra LifeSciences Holdings Corp. – Segment focus
Exhibit 56: Integra LifeSciences Holdings Corp. – Key offerings
Exhibit 57: Katena Products Inc. – Vendor overview
Exhibit 58: Katena Products Inc. – Product segments
Exhibit 59: Katena Products Inc. – Organizational developments
Exhibit 60: Katena Products Inc. – Key offerings
Exhibit 61: MiMedx Group Inc. – Vendor overview
Exhibit 62: MiMedx Group Inc. – Business segments
Exhibit 63: MiMedx Group Inc. – Organizational developments
Exhibit 64: MiMedx Group Inc. – Key offerings
Exhibit 65: NuVision Biotherapies Ltd. – Vendor overview
Exhibit 66: NuVision Biotherapies Ltd. – Business segments
Exhibit 67: NuVision Biotherapies Ltd. – Organizational developments
Exhibit 68: NuVision Biotherapies Ltd. – Key offerings
Exhibit 69: Orthofix Medical Inc. – Vendor overview
Exhibit 70: Orthofix Medical Inc. – Business segments
Exhibit 71: Orthofix Medical Inc. – Organizational developments
Exhibit 72: Orthofix Medical Inc. – Geographic focus
Exhibit 73: Orthofix Medical Inc. – Segment focus
Exhibit 74: Orthofix Medical Inc. – Key offerings
Exhibit 75: Stryker Corp. – Vendor overview
Exhibit 76: Stryker Corp. – Business segments
Exhibit 77: Stryker Corp. – Organizational developments
Exhibit 78: Stryker Corp. – Geographic focus
Exhibit 79: Stryker Corp. – Segment focus
Exhibit 80: Stryker Corp. – Key offerings
Exhibit 81: Surgenex LLC – Vendor overview
Exhibit 82: Surgenex LLC – Product segments
Exhibit 83: Surgenex LLC – Key offerings
Exhibit 84: TissueTech Inc. – Vendor overview
Exhibit 85: TissueTech Inc. – Business segments
Exhibit 86: TissueTech Inc. – Organizational developments
Exhibit 87: TissueTech Inc. – Key offerings
Exhibit 88: Validation techniques employed for market sizing
Exhibit 89: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark